BSE filing, NSE: ZEELEARN. Summary written from the filing by ALFA Finder's alert engine.
Zee Learn Ltd: key numbers
- Share price
- ₹5.68
- Market cap
- ₹186.2 Cr
- Revenue (annual)
- ₹439.1 Cr
- Net profit (annual)
- ₹38.53 Cr
- P/E (TTM)
- 3.8×Sector 34.1×
- Promoter holding
- 14.98%+0.00% QoQ
- FII holding
- 6.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zee Learn Ltd
All →Zee Learn Management Change
Zee Learn's board approved appointing Rakesh Chaturvedi as an Additional Director (Whole-time Director) effective 9 November 2026, subject to shareholder approval. He will also continue as Chief Financial Officer.
Zee Learn Q2 FY27 Results: Net Loss of ₹1.7 Cr, Loss Narrows
Zee Learn Ltd reported revenue from operations of ₹54.6 Cr (+22.1% YoY) and a net loss of ₹1.7 Cr for Q2 FY27.
- Key figure
- Net loss ₹1.7 Cr
Zee Learn Other Announcement
Zee Learn Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Zee Learn Board Meeting Date
Zee Learn Limited has scheduled a board meeting for October 22, 2026, to consider and approve the standalone and consolidated financial results for the quarter ended September 2026.
Zee Learn Other Announcement
Zee Learn Limited filed its quarterly confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, regarding security dematerialization.
Zee Learn Insolvency Petition
Zee Learn reported an insolvency petition filed by Asset Care & Reconstruction Enterprise against it and its subsidiary. The alleged default amount is Rs. 821 crores.
- Value
- ₹821.0 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date